- Home
- ARTW vs IMRN Comparison
ARTW vs IMRN Comparison
Compare ARTW & IMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARTW
- IMRN
- Stock Information
- Founded
- ARTW 1956
- IMRN 1994
- Country
- ARTW United States
- IMRN Australia
- Employees
- ARTW N/A
- IMRN N/A
- Industry
- ARTW Industrial Machinery/Components
- IMRN Biotechnology: Pharmaceutical Preparations
- Sector
- ARTW Industrials
- IMRN Health Care
- Exchange
- ARTW Nasdaq
- IMRN Nasdaq
- Market Cap
- ARTW 8.7M
- IMRN 10.1M
- IPO Year
- ARTW N/A
- IMRN N/A
- Fundamental
- Price
- ARTW $1.50
- IMRN $1.80
- Analyst Decision
- ARTW
- IMRN Strong Buy
- Analyst Count
- ARTW 0
- IMRN 1
- Target Price
- ARTW N/A
- IMRN $5.00
- AVG Volume (30 Days)
- ARTW 13.4K
- IMRN 13.8K
- Earning Date
- ARTW 04-11-2025
- IMRN 04-15-2025
- Dividend Yield
- ARTW N/A
- IMRN N/A
- EPS Growth
- ARTW 17.02
- IMRN N/A
- EPS
- ARTW 0.06
- IMRN N/A
- Revenue
- ARTW $24,499,371.00
- IMRN $4,048,286.00
- Revenue This Year
- ARTW N/A
- IMRN N/A
- Revenue Next Year
- ARTW N/A
- IMRN N/A
- P/E Ratio
- ARTW $26.13
- IMRN N/A
- Revenue Growth
- ARTW N/A
- IMRN 82.90
- 52 Week Low
- ARTW $1.33
- IMRN $1.70
- 52 Week High
- ARTW $4.15
- IMRN $3.09
- Technical
- Relative Strength Index (RSI)
- ARTW 31.94
- IMRN 47.09
- Support Level
- ARTW $1.51
- IMRN $1.73
- Resistance Level
- ARTW $1.64
- IMRN $2.09
- Average True Range (ATR)
- ARTW 0.07
- IMRN 0.16
- MACD
- ARTW -0.02
- IMRN 0.00
- Stochastic Oscillator
- ARTW 0.00
- IMRN 23.08
About ARTW Art's-Way Manufacturing Co. Inc.
Art's-Way Manufacturing Co Inc is a manufacturer of agricultural equipment. It has two reportable segments: Agricultural Products, and Modular Buildings. The Agricultural Products segment fabricates and sells farming products as well as related equipment and replacement parts for these products in the United States and world wide. Its Modular Buildings segment manufactures and installs modular buildings for animal containment and various laboratory uses. It derives revenues from the Agricultural Products segment.
About IMRN Immuron Limited
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.